Abivax increases size of Nasdaq uplisting deal

Abivax S.A.

has increased the size of its global offering to 20.33 million shares from 18.68 million shares as part of its uplisting to the Nasdaq under the ticker symbol “ABVX” from Euronext Paris, according to a filing late Wednesday. Abivax plans to raise about $250 million with underwriters Morgan Stanley and Leerink at an estimated price range of $11.60 a share to $13 a share. The stock is expected to begin trading on Friday on the Nasdaq, according to IPOScoop.com.

Finance Finance Latest News, Finance Finance Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. Bancorp’s stock rallies on release of Fed banking requirementSteve Gelsi covers banking and cannabis as a Senior Reporter for MarketWatch.
Source: MarketWatch - 🏆 3. / 97 Read more »

Goldman's profit estimates trimmed by Jefferies analyst after third-quarter reportSteve Gelsi covers banking and cannabis as a Senior Reporter for MarketWatch.
Source: MarketWatch - 🏆 3. / 97 Read more »

Nasdaq ends down on higher yields, chipmaker share declinesU.S. stocks ended flat to lower on Tuesday as Treasury yields rose and shares of chipmakers fell after the Biden administration said it planned to halt shipments of advanced artificial intelligence chips to China.
Source: Reuters - 🏆 2. / 97 Read more »